CRYSTAPEN
CRYSTAPEN
Discontinued
DIN Number
02060094
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02060094
AIG Number0105887001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CE01 BENZYLPENICILLIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification08:12.16.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
PENICILLIN G SODIUMActive
Strength: 5000000 UNIT / VIAL
Monograph: PENICILLIN G SODIUM